ERAQUELL TABLETS
Contra-indications,
warnings, etc
Do not use in foals under 2 weeks of age. Do not use in horses
known to be hypersensitive to the active ingredient
or any of the other ingredients.Colic, diarrhoea and
anorexia have been reported in very rare occasions
post treatment, in particular when there is heavy
worm burden. In very rare occasions, allergic
reactions such as hypersalivation, lingual oedema,
urticaria, tachycardia, congested mucus membranes,
and subcutaneous oedema have been reported following
treatment with the product.
Special precautions for use in animals
Avermectins may not be well tolerated in non target species. Cases
of intolerance are reported in dogs, especially
Collies, Old English Sheepdogs and related breeds or
crosses, and also in turtles and tortoises.
Dogs and cats should not be allowed to ingest
spilled tablet or have access to used packaging due
to the potential for adverse effects related to
ivermectin toxicity.
Young foals, miniature horses and toy breeds
weighing less than 50 kg may be unable to ingest
tablets. Seek the advice of your
SQP
Uses
For the treatment of nematode and arthropod infestations, due to
adult and immature roundworms and bots in horses:
Nematodes
Large-strongyles:
Strongylus vulgaris
(adult and arterial
larvae)
Strongylus edentatus
(adult and L4 tissue
larval stages)
Strongylus equinus
(adult and L4 larval
stage)
Triodontophorus
spp.
(adult)
Small-strongyles:
Cyathostomum (adult and non-encysted mucosal larvae):
Cylicocyclus
spp.,
Cylicostephanus
spp.,
Gyalocephalus
spp.
Parascaris:
Parascaris equorum
(adult and larvae).
Oxyuris:
Oxyuris
equi
(adult and larvae).
Trichostrongylus:
Trichostrongylus axei
(adult).
Dipteran insects
Gasterophilus
spp.
(larvae).
Special
precautions to be taken by the person administering the
veterinary medicinal product to animals
Wash hands after use. Avoid contact with the eyes. In case of eye
irritation, seek medical attention. Do not eat, drink or smoke
while handling this product. In the event of accidental
ingestion, seek medical advice and show the leaflet to the
physician so that he knows what you have taken.
Special warnings
for target species
Care should be taken to avoid the following practices because they
increase the risk of development of resistance and could
ultimately result in ineffective therapy: too frequent and
repeated use of anthelmintics from the same class over an
extended period of time, underdosing, which may be due to
underestimation of body weight, misadministration of the
product, or lack of calibration of the dosing device (if any).
Suspected clinical cases of resistance to anthelmintics should be
further investigated using appropriate tests (e.g. Faecal Egg
Count Reduction Test). Where the results of the test(s) strongly
suggest resistance to a particular anthelmintic, an anthelmintic
belonging to another pharmacological class and having a
different mode of action should be used.
Resistance to ivermectin has been reported in
Parascaris equorum
in horses. Therefore the use of this product should be based on
local (regional, farm) epidemiological information about
susceptibility of nematodes and recommendations on how to limit
further selection for resistance to anthelmintics.
The product is safe for use in stallions.
Overdose
A tolerance study performed with the product in adult horses with
doses up to 5 times the recommended dosage did not show any
adverse reactions.
Safety studies were conducted with a veterinary medicinal
product containing praziquantel and the same dose of ivermectin
(EQUIMAX oral gel), in mares, stallions and foals.
Administration to mares at 3 times the recommended dosage at 14-day
intervals during the whole gestation and lactation periods did
not result in any abortion, nor any adverse effect during
gestation, at parturition or on the mares general health, nor
any abnormality in the foals.
Administration to stallions at 3 times the recommended dosage did
not show any adverse effect in particular on the reproductive
performances.
Administration to foals with doses up to 5 times the recommended
dosage did not show any adverse reaction.
Withdrawal period:
Horses may be slaughtered for human consumption only after 35
days from the last treatment. Not to be used in horse producing
milk for human consumption
Container disposal:
Any unused veterinary medicinal product or waste materials
derived from such veterinary medicinal products should be
disposed of in accordance with local requirements. EXTREMELY
DANGEROUS TO FISH AND AQUATIC LIFE. Do not contaminate surface
waters or ditches with the product or used container.
18/02/2010
